UBS Downgrades GlaxoSmithKline (GSK) to Sell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
UPDATE: UBS Downgrades GlaxoSmithKline (GSK:LN) (GSK) to Sell
November 11, 2022 5:27 AM EST(Updated - November 11, 2022 7:55 AM EST)
UBS analyst Michael Leuchten downgraded GlaxoSmithKline (GSK:LN) (NYSE: GSK) from Neutral to Sell with a price target of GBP13.00 (from GBP18.20).
The analyst commented, "At face value GSK trades on c9x... More
European stocks edge lower; earnings season in full flow
November 10, 2022 5:23 AM EST
By Peter Nurse
Investing.com - European stock markets traded marginally lower Thursday, with turmoil in the crypto market dampening sentiment while investors continued to digest U.S. midterm elections as well as quarterly corporate results.
At 03:55 ET (08:55 GMT), the DAX index in Germany traded 0.1% lower, CAC 40 in France fell 0.4% and the FTSE 100 in the U.K. dropped 0.1%.
The U.S. political climate remained uncertain Thursday, two days after the midterm elections, with Republicans edging closer to securing a majority in the... More
